V I Maksimov studies how well a medication called Revelise (also known as alteplase) can help patients who have had ischemic strokes, which are caused by blocked blood vessels in the brain. He looks into how this treatment performs in everyday medical settings with actual patients, particularly older individuals and those who may have other health problems. His research aims to uncover how this therapy can help reduce disabilities caused by strokes, thus improving patients' quality of life after such medical emergencies.
Key findings
In a study with 2,202 patients, 49.9% had good outcomes upon discharge after receiving Revelise.
After 90 days, the number of patients with good outcomes increased to 66.4%.
The results show that Revelise effectively reduces disabilities from strokes, particularly in older patients.
Frequently asked questions
Does Dr. Maksimov study ischemic strokes?
Yes, he specifically researches treatments for ischemic strokes using the medication Revelise.
What outcomes are expected with Revelise for stroke patients?
Nearly half of the patients treated with Revelise showed good outcomes when discharged, and this improved to over two-thirds after 90 days.
Is Dr. Maksimov's work relevant for older stroke patients?
Yes, his research particularly highlights the effectiveness of Revelise in older patients and those with other health issues.
Publications in plain English
[Thrombolytic Therapy for Ischemic Stroke with Revelise: Results of a Two-Year Follow-Up in the International PRIMA Study].
2025
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Shamalov NA, Khasanova DR, Marchenko SV, Soldatov MA, Azarova AG +46 more
Plain English This study looked at how well and safely Revelise (alteplase), a medication for treating ischemic stroke (IS), works in real-life situations. It involved 2,202 patients, mostly around 68 years old, and found that nearly half (49.9%) of them had good outcomes when discharged, rising to 66.4% after 90 days. The results showed that Revelise effectively reduces stroke-related disabilities, even in older patients and those with other health issues.
Who this helps: This benefits patients who suffer from ischemic strokes and the doctors treating them.
[The preclinical diagnosis, prevention and treatment of postoperative iridocyclitis in patients after intraocular aphakia correction].
2004
Vestnik oftalmologii
Maksimov VIu, Dmitrieva OG, Aksinenko AM
Plain English This study looked at 352 patients who had surgery for cataracts. Researchers found that infections from the herpes virus and Chlamydia were key factors in causing complications shortly after the surgery. They also discovered that levels of immune cells responsible for fighting infections were significantly lower in patients who developed a specific eye condition called iridocyclitis following the surgery.
Who this helps: This research benefits patients recovering from cataract surgery by identifying risks for complications.
[Use of lactusan for the correction of microecological intestinal disturbances in children].
2002
Zhurnal mikrobiologii, epidemiologii i immunobiologii
Rodoman VE, Maksimov VI, Kuz'menko LG, Petruk NI, Plisov VN +1 more
Plain English This study looked at how lactusan (lactulose) can help fix gut problems in children. Out of 24 sick kids aged 1 month to 15 years, 21 showed noticeable improvement, particularly with diarrhea stopping. In 14 of these children, there was a rise in beneficial bacteria and a drop in harmful ones, showing that lactulose acts as a prebiotic.
Who this helps: This helps children with digestive issues.
[Laser magnetotherapy after cataract extraction with implantation of intraocular lens].
2002
Vestnik oftalmologii
Maksimov VIu, Zakharova NV, Maksimova IS, Golushkov GA, Evseev SIu
Plain English This study looked at how low-intensity laser treatment and magnetic fields can help patients recover after cataract surgery with an intraocular lens. Researchers followed 136 patients with swelling and inflammation in their eyes for up to six months. They found that those who received the laser and magnetic therapy experienced less inflammation and improved healing compared to those who did not, leading to better vision outcomes.
Who this helps: This benefits patients recovering from cataract surgery.
Plain English This research looked at how food starch affects our health, specifically its connection to colon cancer, how it's broken down and processed in our body, and how it impacts our gut bacteria. The study found that certain types of starch can have significant effects on gut health and might influence the risk of developing colon cancer. Understanding these factors is crucial because they can help in creating better dietary guidelines to protect against this common type of cancer.
Who this helps: Patients, especially those at risk for colon cancer.
[Cryogenic effect on renal tissue and condition of intrarenal hemodynamics].
1998
Urologiia i nefrologiia
Beliakova IA, Gudkov AV, Baĭkov AN, Maksimov VI, Kirpatovskiĭ VI
Plain English This study explored how freezing temperatures affect kidney tissue and blood flow in the kidneys. Researchers found that freezing caused damage to the kidney cells, but the blood supply remained mostly unaffected and was redirected through other pathways. This matters because understanding these effects can help improve treatments for kidney injuries and conditions.
Who this helps: Patients with kidney problems.
[The effect of freezing the kidney in the terminal stage of hydronephrosis on its parenchymal function, arterial pressure regulation and erythropoiesis].
1998
Urologiia i nefrologiia
Beliakova IA, Gudkov AV, Baĭkov AN, Maksimov VI, Kirpatovskiĭ VI
Plain English This study looked at the effects of freezing kidneys that are severely damaged by a condition called hydronephrosis. Researchers found that after freezing the kidney, it started to heal about 30 days later, and both blood pressure and red blood cell production returned to normal levels. This is important because freezing the kidney may be a better option than removing it, helping to avoid high blood pressure and anemia in patients.
Who this helps: This benefits patients with advanced hydronephrosis by potentially preserving kidney function.
Plain English This study looked at 96 surgeries done at the same time for patients with peptic ulcers, focusing on when to perform these combined procedures and how to manage other health issues that might complicate them. The researchers found that only 4.2% of patients had complications after surgery, and the death rate was very low at 1.04%, showing that these combined surgeries can be done safely and effectively. This matters because it offers a way to treat patients with complicated conditions more efficiently, reducing their overall risk.
Who this helps: This benefits patients with peptic ulcers and other related health problems.
[Psychogenias of the refusal reaction type in patients with slowly progressive schizophrenia].
1987
Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)
Maksimov VI
Plain English Researchers studied patients with long-term, slowly progressing schizophrenia who showed a specific refusal to engage in activities, often due to negative emotional changes and decreased ability to work. They found that these refusal reactions are linked to a kind of personality issue where patients show traits like dependency and anxiety, leading to behaviors such as avoidance and motor inactivity. Understanding these patterns is important because it can help doctors treat these patients more effectively.
Who this helps: This helps patients with schizophrenia and their healthcare providers.
[Typology of the defect in patients with non-manifest schizophrenia (clinico-psychological study)].
1986
Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)
Maksimov VI, Zverkova IV
Plain English This study looked at how certain mental health challenges affect people with non-manifest schizophrenia over time, particularly focusing on their social abilities. Researchers found two main types of issues: "torpid fanatics," who follow social norms but struggle to adapt, and "dependent personalities," who prioritize personal gain and rely heavily on their close social circles. The findings suggest tailored rehabilitation plans are necessary, with the first group needing guidance on social expectations and the second group benefiting from supervised manual work.
Who this helps: This helps patients with non-manifest schizophrenia and their healthcare providers.
[Localized intravascular coagulation in the microcirculatory bed of the brain in hemorrhagic strokes].
1986
Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)
Maksimov VI, Lukasevich LL
Plain English This research looked at how blood clots form in the tiny blood vessels of the brain during hemorrhagic strokes, which occur when bleeding happens in the brain. The study found that localized clotting leads to more serious circulation problems and can make the affected area of the brain larger, worsening the stroke's impact. Understanding these clotting issues can help doctors find better treatments to manage bleeding in the brain.
Who this helps: This helps patients experiencing hemorrhagic strokes.
Plain English Researchers studied the effects of intensive drug therapy on 120 patients with slowly progressive schizophrenia, a form of the illness that doesn't respond well to standard treatments. They tested two new methods: giving tranquilizers in separate doses and using a steady intravenous drip, both combined with low doses of other medications. The findings support the effectiveness of these approaches, which could significantly improve treatment outcomes for this challenging patient group.
Who this helps: This helps patients with slowly progressive schizophrenia and their doctors.
[Transglycosylation reactions catalyzed by Aspergillus niger 15 beta-xylosidase].
1984
Prikladnaia biokhimiia i mikrobiologiia
Tavobilov IM, Maksimov VI, Rodionova NA
Plain English This study looked at how an enzyme from the fungus Aspergillus niger breaks down certain sugars and creates new sugar compounds from them. Researchers found that when the enzyme acted on two specific sugar compounds, it produced new products in amounts that were 7 to 10 times smaller than the breakdown products. Understanding how this enzyme works is important because it could help in developing better ways to produce valuable sugars for various applications.
Who this helps: This benefits researchers and industries looking to develop new sugar-based products.
[Carbohydrate component of Penicillium funiculosum dextranase].
1983
Prikladnaia biokhimiia i mikrobiologiia
Danilova TI, Maksimov VI, Chukhrova AI, Molodova GA
Plain English This study looked at a specific enzyme called dextranase from a fungus, Penicillium funiculosum, to understand its carbohydrate makeup. Researchers discovered that the enzyme is made up of 313 amino acids and contains carbohydrates in a specific ratio: 6 parts glucosamine to 2 parts mannose and 1 part galactose and fucose. This information is important because it helps in purifying the enzyme, which is essential for various applications in the food and pharmaceutical industries.
Who this helps: This primarily benefits researchers and manufacturers who need to use purified enzymes in their products.
[Detection of transglycosylation reactions under the influence of Trichoderma koningii and Trichoderma viride cellulase].
1981
Prikladnaia biokhimiia i mikrobiologiia
Maksimov VI
Plain English This study looked at how certain enzymes from the fungus Trichoderma koningii and Trichoderma viride help create new sugar compounds. The researchers found that these enzymes produced high-weight sugar products, over 1500 molecular weight, from smaller sugar molecules during the reaction. This matters because understanding these processes can help in developing better ways to produce valuable sugar compounds, which can be used in various industries.
Who this helps: This helps researchers and industries looking to create biofuels or food products more efficiently.
[Purification and properties of low molecular weight endoglucanase of the cellulase complex from Trichoderma koningii].
1980
Biokhimiia (Moscow, Russia)
Churilova IV, Maksimov VI, Klesov AA
Plain English This study focused on a specific enzyme called endoglucanase, which helps break down cellulose from a fungus known as Trichoderma koningii. Researchers isolated a smaller version of this enzyme, which weighs around 13,000 units, and found that it works best when activated by another sugar called cellobiose, increasing its activity six times when enough sugar is present. Understanding how this enzyme functions is important because it can enhance processes in industries like biofuel production by improving cellulose breakdown.
Who this helps: This helps patients by potentially increasing the efficiency of biofuels, leading to cleaner energy options.
[Surgical procedure in stomach and duodenal diseases associated with calculous cholecystitis].
1980
Vestnik khirurgii imeni I. I. Grekova
Myshkin KI, Maksimov VIu
Plain English This study looked at 19 patients who had both stomach problems and gallbladder stones (calculous cholecystitis). All of them underwent surgery at the same time, and there were no complications reported. The researchers concluded that doing both surgeries at once is the best approach, as gallbladder stones could lead to complications after any surgery.
Who this helps: This helps patients with stomach issues and gallbladder stones who need surgery.
[Stabilization of dextranase from Penicillium funiculosum and Fusarium solani during heating and freeze-drying].
1979
Prikladnaia biokhimiia i mikrobiologiia
Maksimov VI, Danilova TI, Khasipdzheva AD, Molodova GA
Plain English This study looked at how to keep a specific enzyme, dextranase, stable during heating and freeze-drying, as these processes typically lead to a significant loss of its activity. Researchers found that using polyglucine hydrolyzate and glucose helped maintain the enzyme's effectiveness, reducing the amount of stabilizer needed by 90% when freeze-drying compared to heating. This is important because it can help create more effective enzyme products for various medical and industrial applications.
Who this helps: This benefits patients and companies that rely on stable enzyme formulations for treatments and products.
[Cellobiose as a regulator of endoglucanase activity of cellulase complexes. Mechanism of the regulation].
1979
Biokhimiia (Moscow, Russia)
Churilova IV, Maksimov VI, Klesov AA
Plain English This study looked at how the sugar cellobiose affects certain enzymes, called endoglucanases, which help break down cellulose. The researchers found that cellobiose hinders the activity of endoglucanases from one source at levels above 3 mM while activating a different type at low levels, increasing its activity six times when cellobiose is saturated (15 mM). Understanding these effects is important because it can help improve processes that rely on breaking down cellulose, such as biofuel production.
Who this helps: This benefits researchers and industries focused on renewable energy and waste management.
[Characteristics of asparaginase from Escherichia coli at different stages of purification].
1976
Prikladnaia biokhimiia i mikrobiologiia
Maksimov VI, Molodova GA, Uvarkina TP, Danilova TI
Plain English This study looked at a protein called asparaginase, which is extracted from E. coli, to understand how it changes through various purification steps. The researchers confirmed that the purified asparaginase was very similar to other known asparaginase products, meaning it has the potential to be used effectively in treatments. This is important because asparaginase is used in cancer therapies to help manage certain types of leukemia.
Who this helps: This helps patients with leukemia who need effective treatment options.
[Effect of different pH values on the activity and quaternary structure of asparaginase in Escherichia coli extracts].
1975
Prikladnaia biokhimiia i mikrobiologiia
Maksimov VI, Molodova GA, Bespalova TI, Denisov VM
Plain English This study looked at how low pH levels affect asparaginase, an enzyme from E. coli, especially during its early purification stages. Researchers found that lowering pH helped separate unwanted proteins without harming the enzyme's activity. They also discovered that when stored at a cooler temperature, the enzyme tended to break apart into smaller units, which is different from how it behaves in a neutral environment.
Who this helps: This benefits researchers and manufacturers working to purify asparaginase for medical use.
[Multiple forms of acid phosphatase of the mould Aspergillus awamori str. 22].
1975
Prikladnaia biokhimiia i mikrobiologiia
Maksimov VI, Kalashnikova NA, Konovalov SA, Kalunyants KA
Plain English This study examined a type of enzyme called acid phosphatase produced by the mould Aspergillus awamori str. 22. Researchers found that this enzyme is not a single form but a mix of different sizes, specifically ranging from 30,000 to 140,000 in molecular weight. As the size of the enzyme molecules increases, their acidity level also increases, going from 4.6 to 5.4 on the pH scale.
Who this helps: This helps researchers and developers working with enzymes for industrial or medical applications.